What should you know about limbic encephalitis?;O que deve saber sobre encefalites auto-imunes?

Arquivos de Neuro-Psiquiatria

Volumn 70, Issue 10, 2012, Pages 817-822

  Machado, Sara ^a,b   Pinto, Amélia Nogueira ^a   Irani, Sarosh R ^c  

^a Hospital Professor Doutor Fernando Fonseca   (Portugal)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CASPR2; Encephalopathy; Immunotherapy; Intracellular antigens; LGI1; Limbic autoimmune encephalitis; Membrane surface antigens; N methylaspartate; Paraneoplastic syndrome; VGKC complex

Indexed keywords

ACICLOVIR; AXONIN 1; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HU ANTIBODY; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENYTOIN; PREDNISOLONE; RITUXIMAB; STEROID; VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; AMNESIA; BLOOD ANALYSIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DISEASE ASSOCIATION; DRUG MEGADOSE; ELECTROENCEPHALOGRAM; HUMAN; IMMUNOTHERAPY; INVOLUNTARY MOVEMENT; IRRITABILITY; MALE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PLASMAPHERESIS; PROGNOSIS; REVIEW; TONIC CLONIC SEIZURE;

EID: 84867864869     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2012001000012     Document Type: Review

References (39)

1. Brierley JB, Corsellis JAN, Hierons R, et al. Subacute encephalitis of later adult life mainly affecting the limbic areas. Brain 1960;83:357-368.
2. Geschwind MD, Tan KM, Lennon VA, et al. Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol 2008;65:1341-1346.
3. Hama K, Ishiguchi H, Tuji T, Miwa H, Kondo T. Neurosyphilis with mesiotemporal magnetic resonance imaging abnormalities. Intern Med 2008;47:1813-1817.
4. Jeong YM, Hwang HY, Kim HS. MRI of neurosyphilis presenting as mesiotemporal abnormalities: a case report. Korean J Radiol 2009;10:310-312.
5. Vincent A, Bien CG, Irani SR, Waters P. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011;10:759-772.
6. Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1-antibody limbic encephalitis. Ann Neurol 2011;69:892-900.
7. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-1140.
8. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004:127;701-712.
9. Tüzün E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 2007;13:261-271.
10. Graus F, Keime-Guibert F, Reñe R, et al. Anti-Hu associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001;124:1138-1148.
11. Voltz R, Gultekin SH, Ronsenfeld MR, et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 1999;340:1788-1795.
12. Dalmau J, Gultekin SH, Voltz R, et al. Ma1, a novel neuron and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 1999;122:27-39.
13. Bataller L, Dalmau J. Paraneoplastic disorders of the nervous system: update on diagnostic criteria and treatment. Semin Neurol 2004;4:461-471.
14. Honnorat J, Cartalat-Carel S, Ricard D, et al. Onconeural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 2009;80:412-416.
15. Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010;67:470-478.
16. Saiz A, Blanco Y, Sabater L, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008;131:2553-2563.
17. Najjar S, Pearlman D, Najjar A, Ghiasian V Zagzag D, Devinsky O. Extralimbic autoimmune encephalitis associated with glutamic acid decarboxylase antibodies: an underdiagnosed entity? Epilepsy Behav 2011;21:306-313.
18. Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurology 2010;257:509-517.
19. Dalmau J, Lancaster E, Martinez-Hernandez Eugenia, Rosenfeld NR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74.
20. Dalmau J, Tüzün E, Wu Hy, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.
21. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010;133:1655-1667.
22. Schimmel M, Bien CG, Vincent A, Schenk W, Penzien J. Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia. Arch Dis Child 2009;94:314-316.
23. Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumour removal. Neurology 2008;70:504-511.
24. Whiteley AM, Swash M, Urich H. Progressive encephalomyelitis with rigidity. Brain 1976;99:27-42.
25. Gabilondo I, Saiz A, Galán L, et al. Analysis of relapses in anti-NMDAR encephalitis. Neurology 2011;77:996-999.
26. Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 2008;70:1883-1890.
27. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734-2748.
28. Jacob S, Irani SR, Rajabally YA, et al. Hypothermina in VGKC antibody-associated limbic encephalitis. J Neurol Neurosurg Psychiatry 2008;79:202-204.
29. Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol. 2012. doi: 10.1002/ana.23577. [Epub ahead of print]
30. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65:424-434.
31. Boronat A, Sabater L, Saiz A, Dalmau J, Graus F. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology 2011;76:795-800.
32. Meinck HM, Thompson PD. Stiff man syndrome and related conditions. Mov Disord 2002;17:853-866.
33. Turner MR, Irani SR, Leite MI, Nithi K, Vincent A, Ansorge O. Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology 2011;77:439-443.
34. Mas N, Saiz A, Leite MI, et al. Antiglycine-receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 2011;82:1399-1401.
35. Carr I. The Ophelia syndrome: memory loss in Hodgkin's disease. Lancet 1982;1:844-845.
36. Fakhoury T, Abou-Khalil B, Kessler RM. Limbic encephalitis and hyperactive foci on PET scan. Seizure 1999;8:427-431.
37. Irani SR, Vincent A. NMDA receptor antibody encephalitis. Curr Neurol Neurosci Rep 2011;11:298-304.
38. Bien CG, Elger CE. Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life. Epilepsy Behav 2007;10:529-538.
39. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000;123:1481-1494.